Original news and analysis on international IP policy
By Tove Iren S. Gerhardsen Intellectual property rights issues could play a significant role in the annual World Health Assembly which begins next week. While not the most prominent topic for the assembly, IP is expected to arise in discussions…
By Tove Iren S. Gerhardsen The government of Brazil has issued a license that will allow the importation of cheaper versions of a patented HIV/AIDS drug after negotiations failed to bring about agreement on price reductions with Merck, the US…
By Tove Iren S. Gerhardsen A team from the independent investigative arm of the United States Congress visited Geneva last week, interviewing insiders from the private sector, non-governmental and international organisations including the World Health Organization (WHO) regarding how the…
By Tove Iren S. Gerhardsen NEW YORK – Speakers at an intellectual property conference here disagreed on the future of the IP system and what role the World Intellectual Property Organization (WIPO) will play during the next 10 years. But…
By Tove Iren S. Gerhardsen BRUSSELS – Whether research and development into new medicines for poor countries may best be secured through the strengthening of current partnerships or through entirely new schemes was the focus of an expert workshop held…
By Tove Iren S. Gerhardsen BRUSSELS – Sixteen member states of the World Health Organization have submitted their views on the way forward for an intergovernmental working group on public health and intellectual property, according to a senior WHO official.…
By Tove Iren S. Gerhardsen A Thai official says the government’s phones have started ringing a lot more frequently since Thailand issued compulsory licenses to import and eventually produce patented medicines, moving patent owners to drop their prices. But sceptics…
By Tove Iren S. Gerhardsen The Indonesian government’s reluctance to share avian influenza virus samples to help develop a global vaccine for humans has revealed a weakness in the international flu research system related to developing countries’ concern with the…
By William New An informative event this week pitted key proponents of opposite views on how to best protect the intellectual property rights of pharmaceutical companies while also addressing the needs of poor patients around the world unable to afford…
By Tove Iren S. Gerhardsen One of the companies whose patent may be overruled by Thailand’s issuance of a compulsory license said it was caught off-guard by the Thai move, which was aimed at reducing drug prices. The Thai government…